GlobalData on MSN17h
FDA fast tracks Bracco’s BR55 for Crohn’s disease bowel inflammation detectionEngineered to specifically act on the vascular endothelial growth factor receptor 2 (VEGFR2), BR55 (perfluorobutane/nitrogen lipopeptide-coated microbubbles) injection claims to i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback